A pilot study towards the immunological effects of omalizumab treatment used to facilitate oral immunotherapy in peanut‐allergic adolescents

Anti‐IgE treatments, such as omalizumab, have shown promising effects in allergy treatment. Our previous work has shown that individualized omalizumab treatment (OT) allows a safe initiation and rapid up‐dosing of peanut oral immunotherapy (OIT) in peanut‐allergic adolescents. However, the broader i...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Heiden, Marieke, Nopp, Anna, Brandström, Josef, Carvalho‐Queiroz, Claudia, Nilsson, Caroline, Sverremark‐Ekström, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Human Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988572/
https://www.ncbi.nlm.nih.gov/pubmed/33244763
http://dx.doi.org/10.1111/sji.13005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988572/
https://www.ncbi.nlm.nih.gov/pubmed/33244763
http://dx.doi.org/10.1111/sji.13005

Ejemplares similares